Global Antibody Drug Conjugate Market is estimated to be US$ 27.0 billion by 2030
Nehashaikh13 Apr, 2022News
The global antibody drug conjugate market accounted for US$ 3.3 billion in 2020 and is estimated to be US$ 27.0 billion by 2030 and is anticipated to register a CAGR of 23.5%. Antibody-drug conjugates or ADCs are biopharmaceutical drugs designed for targeted therapy for treating various type of cancer. ADCs are expose to target and kill tumor cells while sparing healthy cells. As of now 59npharmaceutical companies developed ADCs. These are complex molecules composed of antibody and have capability to target cancer cells by discriminating healthy tissues and diseased tissues.
Related Bookmarks
- Global Power Management Integrated Circuit (IC) Market worth US$ 19.34 Billion 2020 with a CAGR of 4
- battery backup for solar panels
- residential solar
- solar cost
- Online GD&T Training
- Desayuno
- Global Next-Generation Sequencing (NGS) Market is estimated to be US$ 52.40 billion by 2030
- Global Soundproof Curtains Market is estimated to be 2.9 Billion by 2025 with a CAGR of 7.1% during
- Digital Marketing place for top article | Social Bookmarking
- https://www.prophecymarketinsights.com/market_insight/Global-Tinplate-Packaging-Market-4860
Recent Profiles
Relatietherapie Den Haag
Physio Campbelltown
Trang Bongdanet66
Ez Rides Auto Sales & Finance
Sowerby & Moustakis Law
Ergopulse
Martin Sunesen
Chang Arnold
Elliott Mobile Diagnostic & Programming
Chapman May